BioCentury
ARTICLE | Company News

Procarta, University of East Anglia Medical School deal

March 18, 2013 7:00 AM UTC

Procarta said it received a £50,000 ($74,665) grant from the medical school to develop a nasal spray formulation of the company's methicillin-resistant Staphylococcus aureus (MRSA) antibiotic to preve...